title: [Treatment of carotid artery aneurysms with covered stents].
abstract: OBJECTIVE
  Evaluation of the use of covered stents in treating pseudoaneurysms of the cervical and intracranial/extradural carotid artery and determination of the periprocedural and short- to mid-term complication rate.
  
  
  METHODS
  8 patients with 9 spontaneous dissecting aneurysms of the cervical carotid artery--5 of which were symptomatic--plus one patient with ofthalmoplegia due to an aneurysm of the cavernous carotid artery were studied. While the latter was treated with a PTFE-covered balloon-mounted stainless steel stent (Jostent/Graftmaster), a self-expanding PTFE-covered Nitonol Stent (Symbiot) was used in all other cases. Intervention was performed with local anesthesia. Aspirin and Clopidogrel were both used as antiplatelet drugs. Clinical signs and symptoms and vascular imaging with DS, MR, CT angiography and ultrasound were recorded during patient follow-up, with a mean follow-up period of 14.6 months (4 - 30).
  
  
  RESULTS
  We were able to treat 8 out of 10 aneurysms (80%) using covered stents. The aneurysms were immediately occluded and the associated stenoses of the parent vessel were eliminated. No clinically relevant complications occurred during the procedure or in the follow-up interval. In two cases, elongation of the carotid artery prevented the stent from being positioned over the aneurysm neck. These cases were shown to be stable with the use of antiplatelet drugs.
  
  
  CONCLUSIONS
  Covered stents can be used in the treatment of pseudoaneurysms of the carotid artery as an alternative to long-term antithrombotic medication or surgery. In our study treatment was effective (80%) and free of complications in the short- and mid-term follow-up. Possible indications, technique and the use of imaging modalities for patient follow-up are discussed.
authors.affiliation: Neurochirurgie Neuroradiologie, UKSH Campus Kiel. axel.rohr@gmx.de
authors.forename: A
authors.initials: A
authors.lastname: Rohr
authors.forename: K
authors.initials: K
authors.lastname: Alfke
authors.forename: L
authors.initials: L
authors.lastname: Dörner
authors.forename: T
authors.initials: T
authors.lastname: Bartsch
authors.forename: R
authors.initials: R
authors.lastname: Stingele
authors.forename: O
authors.initials: O
authors.lastname: Jansen
mesh_terms: D000328:Adult; D000497:Alloys; D000784:Aortic Dissection / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery*; D015901:Angiography, Digital Subtraction; D017130:Angioplasty; D001241:Aspirin / Q000627:therapeutic use; D002340:Carotid Artery Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery*; D002342:Carotid Artery, External; D002533:Cerebral Angiography; D000077144:Clopidogrel; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011138:Polytetrafluoroethylene; D015607:Stents / Q000592:standards; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome